55 related articles for article (PubMed ID: 37324189)
21. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.
Hong ZF; Zhang WQ; Wang SJ; Li SY; Shang J; Liu F; Shen DY
Biomed Pharmacother; 2020 Mar; 123():109766. PubMed ID: 31846841
[TBL] [Abstract][Full Text] [Related]
22. DPY30 regulates cervical squamous cell carcinoma by mediating epithelial-mesenchymal transition (EMT).
He FX; Zhang LL; Jin PF; Liu DD; Li AH
Onco Targets Ther; 2019; 12():7139-7147. PubMed ID: 31564898
[TBL] [Abstract][Full Text] [Related]
23. Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth.
Shah KK; Whitaker RH; Busby T; Hu J; Shi B; Wang Z; Zang C; Placzek WJ; Jiang H
Exp Cell Res; 2019 Sep; 382(2):111485. PubMed ID: 31251903
[TBL] [Abstract][Full Text] [Related]
24. Loss of chromatin modulator Dpy30 compromises proliferation and differentiation of postnatal neural stem cells.
Zhao T; Hong Y; Ming GL; Song H
J Mol Cell Biol; 2019 May; 12(1):2-3. PubMed ID: 31125409
[No Abstract] [Full Text] [Related]
25. DPY30 functions in glucose homeostasis via integrating activated histone epigenetic modifications.
Liu B
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):286-290. PubMed ID: 30448059
[TBL] [Abstract][Full Text] [Related]
26. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
[TBL] [Abstract][Full Text] [Related]
27. Structure and Conformational Dynamics of a COMPASS Histone H3K4 Methyltransferase Complex.
Qu Q; Takahashi YH; Yang Y; Hu H; Zhang Y; Brunzelle JS; Couture JF; Shilatifard A; Skiniotis G
Cell; 2018 Aug; 174(5):1117-1126.e12. PubMed ID: 30100186
[TBL] [Abstract][Full Text] [Related]
28. Multiple treatment lines and prognosis in metastatic colorectal cancer patients.
Carlomagno C; De Stefano A; Rosanova M; De Falco S; Attademo L; Fiore G; De Placido S
Cancer Metastasis Rev; 2019 Jun; 38(1-2):307-313. PubMed ID: 30003458
[TBL] [Abstract][Full Text] [Related]
29. WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.
Neilsen BK; Chakraborty B; McCall JL; Frodyma DE; Sleightholm RL; Fisher KW; Lewis RE
BMC Cancer; 2018 Jun; 18(1):673. PubMed ID: 29925347
[TBL] [Abstract][Full Text] [Related]
30. Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer.
Yang Z; Shah K; Busby T; Giles K; Khodadadi-Jamayran A; Li W; Jiang H
J Clin Invest; 2018 Aug; 128(8):3605-3618. PubMed ID: 29870403
[TBL] [Abstract][Full Text] [Related]
31. Histone H3K4 methylation-dependent and -independent functions of Set1A/COMPASS in embryonic stem cell self-renewal and differentiation.
Sze CC; Cao K; Collings CK; Marshall SA; Rendleman EJ; Ozark PA; Chen FX; Morgan MA; Wang L; Shilatifard A
Genes Dev; 2017 Sep; 31(17):1732-1737. PubMed ID: 28939616
[TBL] [Abstract][Full Text] [Related]
32. Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse.
Werdyani S; Yu Y; Skardasi G; Xu J; Shestopaloff K; Xu W; Dicks E; Green J; Parfrey P; Yilmaz YE; Savas S
Cancer Med; 2017 Jun; 6(6):1220-1232. PubMed ID: 28544645
[TBL] [Abstract][Full Text] [Related]
33. Diverse roles of WDR5-RbBP5-ASH2L-DPY30 (WRAD) complex in the functions of the SET1 histone methyltransferase family.
Ali A; Tyagi S
J Biosci; 2017 Mar; 42(1):155-159. PubMed ID: 28229975
[TBL] [Abstract][Full Text] [Related]
34. Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells.
Yang Z; Shah K; Khodadadi-Jamayran A; Jiang H
J Exp Med; 2016 Oct; 213(11):2349-2364. PubMed ID: 27647347
[TBL] [Abstract][Full Text] [Related]
35. Murine Model for Colitis-Associated Cancer of the Colon.
Snider AJ; Bialkowska AB; Ghaleb AM; Yang VW; Obeid LM; Hannun YA
Methods Mol Biol; 2016; 1438():245-54. PubMed ID: 27150094
[TBL] [Abstract][Full Text] [Related]
36. Global patterns and trends in colorectal cancer incidence and mortality.
Arnold M; Sierra MS; Laversanne M; Soerjomataram I; Jemal A; Bray F
Gut; 2017 Apr; 66(4):683-691. PubMed ID: 26818619
[TBL] [Abstract][Full Text] [Related]
37. Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.
Yang Z; Augustin J; Hu J; Jiang H
PLoS One; 2015; 10(12):e0145336. PubMed ID: 26691508
[TBL] [Abstract][Full Text] [Related]
38. Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells.
Lee YJ; Han ME; Baek SJ; Kim SY; Oh SO
PLoS One; 2015; 10(7):e0131863. PubMed ID: 26147337
[TBL] [Abstract][Full Text] [Related]
39. Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.
Chen X; Xie W; Gu P; Cai Q; Wang B; Xie Y; Dong W; He W; Zhong G; Lin T; Huang J
Sci Rep; 2015 Feb; 5():8293. PubMed ID: 25656485
[TBL] [Abstract][Full Text] [Related]
40. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors.
Crncec I; Pathria P; Svinka J; Eferl R
Methods Mol Biol; 2015; 1267():145-64. PubMed ID: 25636468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
